Mechanisms and clinical activity of an EGFR and HER2 exon 20–selective kinase inhibitor in non–small cell lung cancer
Published Online: 2018-04-23
Journal: Nature Medicine•Publisher: Springer Science and Business Media LLC
Authors: Adriana Estrada-Bernal•Alissa Poteete•Anh T. Le•Anna Truini•Brett W. Carter•Charles Lu•Emily Roarty•Huiying Sun•Jacqulyne P. Robichaux•John V. Heymach•Julie R. Brahmer•Katerina Politi•Kwok-Kin Wong•Mehmet Altan•Monique B. Nilsson•Robert C. Doebele•Sarah B. Goldberg•Shengwu Liu•Shuai Li•Shuxing Zhang•Ting Chen•Vassiliki Papadimitrakopoulou•Yasir Y. Elamin•Zhi Tan
